Trojan Bio (Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$13,500,000
Company Info
Founders
Anat Burkovitz
Market
Healthcare & Wellness
Coinvestors
NFX
Company Description

A pre-clinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of difficult-to-treat cancers. TrojanBio is a pharmaceutical company that develops therapeutic antibody solutions related to anti-viral immunity and various cancer types.